<DOC>
	<DOC>NCT02168309</DOC>
	<brief_summary>This study's aim is to determine whether oral extended release nifedipine is superior to oral labetolol for the management of postpartum severe hypertension, specifically time to achieve goal blood pressure, and shortening hospital stay. Our hypothesis is that oral extended release nifedipine is superior to oral labetolol for achieving goal blood pressure in the postpartum period.</brief_summary>
	<brief_title>Oral Nifedipine Versus Oral Labetalol</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<criteria>Age ≥ 18 years with the abililty to give informed consent Intrauterine pregnancy ≥ 32 weeks Postpartum Persistent postpartum blood pressures ≥ 160/105 on two or more occasions Primary obstetrician amenable to starting either study medication in the postpartum period Use of other oral antihypertensives concomitantly Known AV heart block HR &lt;60 or &gt;120 Absolute contraindication to nifedipine or labetolol such as allergy Significant renal disease (Cr &gt;1.5 mg/dL) Heart failure Moderate persistent or severe asthma Preexisting diagnosis of chronic hypertension with medical treatment before delivery Chronic hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>